APP and early-onset autosomal dominant Alzheimer disease: In animal studies, beta-amyloid peptides such as APP (amyloid beta precursor protein) was shown to enhance SNCA (∝-synuclein) accumulation leading to neuronal deficits in a transgenic mouse model linking neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease53.